Exclusive Interview with MediPharm Labs Co-Founder and President Keith Strachan MediPharm Labs (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ), focused solely on producing cannabis concentrates, has a leading revenue position in the Canadian cannabis market. Co-Founder and President Keith Strachan spoke with New Cannabis Ventures about the company’s approach to... Read more
Throughout the healthcare industry, telemedicine technologies and services are becoming increasingly popular. Typically, these products provide ways for patients to interact with healthcare providers. Telemedicine services can cover anything from a remote checkup to a remote visit to obtain a prescription. And now, the trend is catching on in... Read more
MADISON, Wis. (AP) — Gov. Tony Evers on Tuesday signed into law a bipartisan bill that makes Wisconsin’s hemp-growing program permanent as it continues to surge in popularity in just its second year. Hailed by supporters as Wisconsin’s “comeback crop,” hemp is seeing renewed popularity in large part because... Read more
The U.S. Food and Drug Administration detailed its concerns regarding the safety of CBD on Tuesday while issuing warnings to 15 companies the agency says are illegally marketing products containing the cannabinoid. In a consumer update posted to its website, the FDA said that only one pharmaceutical, Epidiolex, has... Read more
BOSTON (AP) — Massachusetts became the first state to ban the sale of flavored tobacco and vaping products, including menthol cigarettes, after the Republican governor signed a bill Wednesday that responds to recent deaths linked to e-cigarettes and attempts to reduce their appeal to young people. Anti-smoking groups hailed... Read more
Former vice president and 2020 Democratic presidential candidate Joe Biden’s views on cannabis appear to be evolving. During a conference call with reporters Monday, Biden reversed his previous stance that marijuana is a “gateway drug.” Biden told reporters that he hasn’t seen evidence to support the gateway drug theory... Read more
Legalization advocates aren’t the only ones who recognize that marijuana’s current restrictive federal classification inhibits research. Recently, a group involving several of the nation’s leading prohibition supporters raised this issue with Congress. Friends of the National Institute On Drug Abuse (FNIDA) submitted recommended language on the issue to a... Read more
Legalization advocates aren’t the only ones who recognize that marijuana’s current restrictive federal classification inhibits research. Recently, a group involving several of the nation’s leading prohibition supporters raised this issue with Congress. Friends of the National Institute On Drug Abuse (FNIDA) submitted recommended language on the issue to a... Read more
BOSTON (AP) — Boston is overhauling its process of reviewing marijuana businesses to boost involvement of minority entrepreneurs in Massachusetts’ burgeoning pot industry. The City Council on Wednesday approved an ordinance calling for the creation of an independent Cannabis Board to oversee local review of prospective marijuana businesses. The... Read more
